Elderly Esophageal Cancer Patients Receive Suboptimal Therapy by Angela Mohan on February 10, 2021 at 2:25 PM
Patients aged above 70 years with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer should be provided with optimal therapy that has the potential to cure, which includes initial chemoradiotherapy (NACR) and surgical resection.
According to researchers, this recommended therapy is often not offered to elderly patients out of concern that they will not tolerate such an intensive treatment regimen.
In a new study, they found that older patients who received the therapy had outcomes comparable with those of younger patients (under 70 years old).
Journal of the American College of Surgeons in advance of print.
New Global Coalition Aims to Eliminate Structural Barriers to Fight Cancer Crisis in Resource-Limited Countries in Africa
Share Article
Collaboration on Implementation Science Research in Global Oncology awards $500,000 to eight country-specific pilot projects in quest to develop sustainable best practices We have to look across the spectrum of cancer care capacity building and select certain projects to pilot in different countries, evaluate how they work and, if we, can replicate them in other countries,” said Ute Dugan, MD, co-founder of CIRGO. CHICAGO (PRWEB) February 09, 2021 A group of global oncology organizations have joined forces to establish the Collaboration on Implementation Science Research in Global Oncology (CIRGO) to improve the coordination of cancer care systems in low- and middle-income countries, particularly in Africa.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stanford Medicine and Sutter Health to Jointly Provide Cancer Care for Patients and Families in .
Sutter HealthFebruary 9, 2021 GMT
Sacramento, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) Sutter Health and Stanford Medicine have formalized a joint venture between the two health systems to expand access to coordinated, state-of-the-art cancer services for patients and their families in the East Bay. The Stanford Medicine | Sutter Health Cancer Collaborative will offer residents and their families an integrated and comprehensive suite of outpatient cancer-related services, including seamless coordination of early detection, cancer care and support programs. The joint venture also includes the construction of an integrated, multidisciplinary outpatient cancer center.
Date Time
Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks
Older patients who do receive recommended multimodal therapy, including surgery, have outcomes comparable with those of younger patients
CHICAGO: Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to cure. This therapy regimen includes initial chemoradiotherapy (NACR) and surgical resection, an operation that removes the cancerous part of the organ.
According to researchers, this recommended therapy is often not offered to elderly patients out of concern that they will not tolerate such an intensive treatment regimen. In a new study, they found that older patients who received the therapy had outcomes comparable with those of younger patients (under 70 years old). The single-institution study from the Ochsner Clinic
Patrick Delaney Named New Executive Director of NCCN Foundation
Incoming leader to oversee fundraising to share trustworthy information about cancer for patients and caregivers as well as supporting promising early-career cancer researchers.
News provided by
Share this article
®. Delaney has previously held leadership roles with the Juvenile Diabetes Research Foundation, American Red Cross, and American Cancer Society. His new position with NCCN will involve fundraising for the NCCN Guidelines for Patients
® and other resources to empower people with cancer and their caregivers with unbiased expert guidance from the world s leading cancer experts. Delaney will also work with NCCN Foundation Young Investigator Awards Program by funding some of the nation s top next-generation cancer researchers, guiding the course of treatment innovation and advancement.